Associate Professor Duke University School of Medicine Duke University Cary, North Carolina, United States
Please join us for a discussion on the pathology of red blood cell sickling and how this may lead to subsequent anemia and hemolysis. We will also review the efficacy and safety of a prescription treatment option for sickle cell disease.
Learning Objectives:
Recognize the goals of the PROSPECT registry, a prospective, long-term real-world study
Understand the clinical outcomes in patients receiving voxelotor as part of their usual care in the PROSPECT study
Consider the interim analysis for patients currently enrolled in the PROSPECT study